Related Experiment Video
Updated: Jun 29, 2026
10:16
Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
Published on: February 8, 2017
A new probe for targeting drug delivery system.
Zhengwen Yu1, Bochu Wang, Jing Sui
1College of Bioengineering, Chongqing University, Chongqing 400030, China.
Medical Hypotheses
|October 3, 2008
Summary
Targeting drug delivery systems (TDDS) can improve anti-tumor drug effectiveness. Attaching artemisinin analogs to drugs offers a novel strategy for precise cancer targeting with potentially fewer side effects.
Area of Science:
- Pharmacology
- Oncology
- Drug Delivery Systems
Background:
- Targeting drug delivery systems (TDDS) are crucial for enhancing anti-tumor drug bioavailability and precision.
- Current methods face challenges in rapidly and accurately delivering drugs to target sites.
- Artemisinin and its analogs show promise for precise cancer cell targeting with minimal impact on healthy tissues.
Purpose of the Study:
- To explore the potential of conjugating artemisinin analogs with existing anti-tumor drugs.
- To develop a novel drug delivery system for improved cancer treatment.
- To leverage the targeting capabilities of artemisinin for enhanced therapeutic outcomes.
Main Methods:
- Review of existing research on TDDS and artemisinin's properties.
- Conceptualization of attaching artemisinin analogs as probes to anti-tumor drugs.
- Exploration of potential conjugation strategies.
Main Results:
- Artemisinin analogs possess inherent cancer-targeting properties.
- Conjugation offers a viable approach to create novel targeted anti-tumor drugs.
- This strategy has the potential to overcome current drug delivery limitations.
Conclusions:
- Combining artemisinin analogs with anti-tumor drugs presents a promising future strategy.
- This novel approach could significantly enhance cancer treatment efficacy.
- The development of such targeted systems represents a powerful advancement in combating cancer.
Related Concept Videos
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:27Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...